Takara Bio Inc. (OTCMKTS:TKBIF) Sees Significant Growth in Short Interest

Takara Bio Inc. (OTCMKTS:TKBIF) was the target of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 69,100 shares, a growth of 31.9% from the March 31st total of 52,400 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Takara Bio Price Performance

Shares of TKBIF remained flat at $23.20 during midday trading on Monday. The stock has a fifty day simple moving average of $23.20 and a 200 day simple moving average of $23.20. Takara Bio has a twelve month low of $23.20 and a twelve month high of $23.20.

About Takara Bio

Takara Bio Inc, together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names.